MentalHealthDaily

Sex-Specific Biomarkers in Antidepressant Treatment for Depression: Male vs. Female (2023 Review)

by GLOOM

Depression, a complex and multifaceted disorder, presents differently in men and women, not only in symptoms but also in how each sex/gender responds to treatment. This divergence has led scientists to explore the molecular mechanisms behind these differences, revealing intricate biological and neurochemical pathways. Highlights: Sex-Specific Prevalence and Symptoms: Women are twice as likely as …

Psilocybin for Depression: Optimal Dosages for Antidepressant Effects (2023 Review)

by GLOOM

Recent research has provided compelling evidence on the therapeutic potential of psilocybin, a naturally occurring psychedelic, in treating depression. A systematic review and dose-response meta-analysis shed light on the optimal dosage of psilocybin for depression, revealing variations in effectiveness based on patient subgroups and associated risks. Highlights: Psilocybin showed significant antidepressant effects, with optimal dosages …

Brain Biomarkers in Suicide Attempts: Elevated 5-HT1A Heteroreceptors & Hyperactivity in Superior Temporal Gyrus (2023 Review)

by GLOOM

Suicide, a tragic end to around 800,000 lives each year, remains one of the most perplexing and devastating phenomena in mental health. Despite the vast number of studies and data, accurately predicting who is at risk of suicide has remained largely elusive, with current tools heavily reliant on subjective assessments and the clinician’s experience. A …

Berberine for Depression: Mechanisms & Antidepressant Effects (2024 Review)

by GLOOM

Depression, a pervasive global health issue, significantly impairs quality of life and burdens the healthcare system. Despite the availability of numerous antidepressants, their effectiveness is often limited, pushing researchers to explore alternative treatments. Berberine, a natural compound with a diverse pharmacological profile, has shown promising antidepressant effects, offering a potential complementary or alternative approach to …

Targeting the Nucleus Accumbens D1-MSN cAMP for Depression & Crocin’s Rapid Antidepressant Effect (2024 Study)

by GLOOM

Depression, a debilitating mental health disorder, has long puzzled scientists and clinicians alike. Recent research sheds light on the nucleus accumbens (NAc), a brain region associated with reward and pleasure, highlighting its critical role in the pathophysiology of depression. Specifically, the study shows how manipulating cyclic adenosine monophosphate (cAMP) levels within dopamine D1 receptor medium …

Accelerated TMS for Depression: Is aTMS More Effective than Standard TMS? (2024 Review)

by GLOOM

Depression, a common yet severe mood disorder, affects millions worldwide, posing significant challenges in both diagnosis and treatment. Recent advancements have led to the development of accelerated transcranial magnetic stimulation (aTMS), a novel approach aiming to offer rapid relief for individuals suffering from major depressive disorder (MDD). This revolutionary technique has shown promising results, potentially …

Approximately 13% of Psychiatrists with Major Depression in Thailand: Loneliness & Work Stress Factors (2024 Study)

by GLOOM

Depression, a pervasive mental health issue, affects individuals across various professions, including those within the psychiatric field. A recent study in Thailand sheds light on the prevalence and associated factors of Major Depressive Disorder (MDD) among psychiatrists and psychiatry trainees, offering insights into the mental well-being of those expected to be at the forefront of …